International Journal of Drug Delivery Technology
Volume 14, Issue 1

Comprehensive Study of Ehretia laevis in Treatment of Diabetes and Related Complications

Sukeshini Lote, Mahendra Kshirsagar, Deepak Mohale, Anil Chandewar

Wadhwani College of Pharmacy, Yavatmal, Maharashtra, India. 

Received: 19th November, 2023; Revised: 21st December, 2023; Accepted: 28th February, 2024; Available Online: 25th March, 2024

ABSTRACT

Diabetes mellitus appears to be a significant health issue globally, impacting millions of individuals and imposing an economic strain on healthcare systems all over the world. The pursuit of effective and safe alternative therapies has led researchers to investigate therapeutic plants with probable antidiabetic activity. This article highlights a comprehensive study investigating the therapeutic potential of Ehretia laevis in controlling of diabetes and associated complications in rats. The phytochemical investigation of E. laevis extracts observed phytoconstituents like flavonoids, phenolics, and triterpenoids. These phytoconstituents are known to possess antidiabetic properties. By injecting 60 mg/kg of STZ intraperitoneally once, rats were induced to develop diabetes. According to the experimental study, blood glucose levels were significantly reduced from 270 to 118 mg/dl after administering 200 and 400 mg/kg of aqueous and methanolic E. laevis extracts. Further evaluations on serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) revealed a significant reduction in their values, highlighting the control of liver complications. A lowering of serum urea and creatinine levels served to assess kidney-related complications. This comprehensive study sheds light on the potential of E. laevis in the treatment of diabetes and paves a path for the development of formulations, however, further mechanistic evaluation could be explored.

Keywords: Ehretia laevis, Diabetic mellitus, Antidiabetic, Complications.

International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.1.60

How to cite this article: Lote S, Kshirsagar M, Mohale D, Chandewar A. Comprehensive Study of Ehretia laevis in Treatment

of Diabetes and Related Complications. International Journal of Drug Delivery Technology. 2024;14(1):412-416.

REFERENCES

  1. A m e r i c a n D i a b e t e s A s s o c i a t io n . D i a g n o s i s a n d classification of diabetes mellitus. Diabetes care. 2010 Jan 1;33(Supplement_1):S62-9.
  2. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related Physical therapy. 2008 Nov 1;88(11):1254-64.
  3. Pradeepa R, Mohan Epidemiology of type 2 diabetes in India. Indian journal of ophthalmology. 2021 Nov 1;69(11):2932-8.
  4. Pandey MM, Rastogi S, Rawat Indian traditional ayurvedic system of medicine and nutritional supplementation. Evidence- based Complementary and Alternative Medicine: Ecam. 2013 Jun 23;2013:376327.
  5. Sharma P, Shri R, Ntie-Kang F, Kumar S. Phytochemical and ethnopharmacological perspectives of Ehretia laevis. 2021 Jun 8;26(12):3489.
  6. Thakre R, Bhake A, Tekade P, Harne K, Borkar PS. Evaluation of Ehretia laevis (Khandu Chakka/Ajan Vruksha) in the Wound Healing Adjudged by Histological Examination of the Tissue. Indian Journal of Forensic Medicine & Toxicology. 2021 Mar 24;15(2):713-21.
  7. Tichkule SV, Khandare KB, Shrivastav Role of Khanduchakka (Ehretia laevis) Lepan (local application) in the management of delayed union of metatarsal fracture: A case report. Journal of Indian System of Medicine. 2019 Apr 1;7(2):127-30.
  8. Rangnathrao TS, Shanmugasundaram Antioxidant and Hepatoprotective activity of Ehretia laevis Roxb against paracetamol induced acute Hepatotoxicityin wistar rats. Research Journal of Pharmacy and Technology. 2019;12(12):6143-8.
  9. Thakre R, Harne K, Tekade P, Parve S. Role of Ajan Vruksha/ Khandu Chakka plant (Ehretia laevis ) in COVID-19 pandemic. Int. J. Res. Pharm. Sci. 2020:224-33.
  10. Velappan S, Thangaraj P. Phytochemical Constituents and Antiarthritic Activity of E hretia laevis Roxb. Journal of food biochemistry. 2014 Aug;38(4):433-43.
  11. Yende SR, Shah SK, Arora SK, Moharir KS, Lohiya GK. In silico prediction of phytoconstituents from Ehretia laevis targeting TNF-α in arthritis. Digital Chinese Medicine. 2021 Oct 1;4(3):180-90.
  12. Doijad C, Bhagat S, Mahajan S, Barsagade G., Development and preparation of pain balm from Ehretia leavis and it’s physiochemical evaluation. Journal of Critical Reviews. 2020;07(17):3874-87.
  13. Alqahtani A, Hamid K, Kam A, Wong KH, Abdelhak Z, Razmovski-Naumovski V, Chan K, Li KM, Groundwater PW, Li The pentacyclic triterpenoids in herbal medicines and their pharmacological activities in diabetes and diabetic complications. Current Medicinal Chemistry. 2013 Mar 1;20(7):908-31.
  14. Verma L, Khatri A, Kaushik B, Patil UK, Pawar Antidiabetic activity of Cassia occidentalis (Linn) in normal and alloxan- induced diabetic rats. Indian journal of pharmacology. 2010 Jul 1;42(4):224-8.
  15. Sagbo I. J, van de Venter M, Koekemoer T, Bradley G, In vitro antidiabetic activity and mechanism of action of Brachylaena elliptica (Thunb.) DC. Evidence-Based Complementary and Alternative Medicine. 2018 Jul 4;2018:e4170372.
  16. Pandya D, Nagrajappa AK, Ravi Assessment and correlation of urea and creatinine levels in saliva and serum of patients with chronic kidney disease, diabetes and hypertension–a research study. Journal of clinical and diagnostic research: JCDR. 2016 Oct;10(10):ZC58.
  17. Joshi DD, Deb L, Somkuwar BG, Rana VS. Relevance of Indian traditional tisanes in the management of type 2 diabetes mellitus: A review. Saudi Pharmaceutical Journal. 2023 May 1;31(5):626-38.
  18. Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash S.K, Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomedicine & Pharmacotherapy. 2018;107:306-328.
  19. Hahr A J, Molitch M E, Management of diabetes mellitus in patients with chronic kidney disease. Clinical Diabetes and Endocrinology. 2015;1(1):2.
  20. Akbarzadeh A, Norouzian D, Mehrabi MR, Jamshidi SH, Farhangi A, Verdi AA, Mofidian SM, Rad BL. Induction of diabetes by streptozotocin in rats. Indian Journal of Clinical Biochemistry. 2007 Sep;22:60-4.
  21. Pandey S, Chmelir T, Chottova Dvorakova Animal Models in Diabetic Research-History, Presence, and Future Perspectives. Biomedicines. 2023;11(10):2852.
  22. El-Kordy EA, Alshahrani AM. Effect of genistein, a natural soy isoflavone, on pancreatic β-cells of streptozotocin-induced diabetic rats: Histological and immunohistochemical study. Journal of Microscopy and Ultrastructure. 2015;3(3):108-119.
  23. Wollenweber LE, Cody V, Middleton EJ, Harborne JB, Beretz Plant flavanoids in biology and medicineII: Biochemical, cellular and medicinal properties. Prog Clin Biol Res. 1988;280:1-461.
  24. Fadheel Prevalence of Diabetes Mellitus and It’s Complications in Iraq. Prevalence of Diabetes Mellitus and It’s Complications in Iraq. International Journal of Pharmaceutical Quality Assurance 2018; 9(2); 109-116.
  25. Al-Chalabi, S.M.M., Abdul-Lattif, R.F., Al-Mahdawi, F.A. and Abud, H.N. Effect of fenugreek (Trigonella foenum graecum) seed aqueous extract on blood glucose, lipid profile and some hormonal assay in Streptozotocin-induced diabetic male albino rats. International Journal of Drug Delivery Technology, 2019; 39 (3): 67-71.